In vitro to in vivo benchmark dose comparisons to inform risk assessment of quantum dot nanomaterials
This article is categorized under:
Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials
Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine
Benchmark dose analysis can be used to compare effects of quantum dots in vitro to predict sensitivity of cell types, assays, and strains. Dosimetry was found to be critical for both in vitro and in vivo comparisons.
Source: Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology - Category: Nanotechnology Authors: Brittany A. Weldon, William C. Griffith, Tomomi Workman, David K. Scoville, Terrance J. Kavanagh, Elaine M. Faustman Tags: ADVANCED REVIEW Source Type: research